Patents by Inventor Priscilla A. Sturm

Priscilla A. Sturm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5047533
    Abstract: Certain open chain purine nucleoside phosphonate derivatives have antiviral activity against the Herpes group of viruses, and also show effective antiviral activity against retroviruses, including human immunodeficiency virus (HIV). These compounds have the formula ##STR1## wherein B represents a substituted or unsubstituted purine base, especially adenine or guanine and their halogenated derivatives. R1 is selected from H, methyl, hydroxymethyl, halomethyl, azidomethyl, and cyano; R2 is selected from H, methyl, hydroxymethyl, halomethyl, azidomethyl, cyano, and OH; also when R2 is OH the carbon to which it is attached may be oxidized so that the H there shown and R2 together may be =0; and n is an integer of 0-5. The compounds of the invention further include the pharmaceutically acceptable mono and dibasic salts and the mono- and diesters of the phosphonate moiety and the acid addition salts of the murine-substituted purines. In addition, when R1 or R2 is --CH.sub.
    Type: Grant
    Filed: January 22, 1990
    Date of Patent: September 10, 1991
    Assignee: SRI International
    Inventors: Elmer J. Reist, Priscilla A. Sturm
  • Patent number: 4056535
    Abstract: The compounds 3-(N-diethylcarbamyl)amino-1-methyl pyrrolidine, 3-(N-carbethoxy-N-methyl)amino-1-methyl pyrrolidine, 1-diethylcarbamyl-3-(N-methyl)amino pyrrolidine and 1-diethylcarbamyl-3-dimethylamino pyrrolidine, said compounds having utility as antifilarial agents.
    Type: Grant
    Filed: April 23, 1976
    Date of Patent: November 1, 1977
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3954766
    Abstract: The compounds 4-carbethoxy-1,4-diazabicyclo[3.2.1]octane and 4-diethylcarbamyl-1,4-diazabicyclo[3.2.1]octane, said compounds having utility as antifilarial agents.
    Type: Grant
    Filed: July 9, 1975
    Date of Patent: May 4, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3951980
    Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo[2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: April 20, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm
  • Patent number: 3947445
    Abstract: Twelve analogs of diethylcarbamazine as prepared by acylation of 3- and 8-methyl-3,8-diazabicyclo[3.2.1]octane, 2-methyl-2,5-diazabicyclo[2.2.2]octane, and 2-methyl-2,5-diazabicyclo [2.2.1]heptane with diethylcarbamyl chloride, ethyl chloroformate, ethyl isocyanate, and cyclohexanecarbonyl chloride. These compounds are formally derived from diethylcarbamazine in possessing two- or one-carbon bridges over the piperazine ring. The compounds have utility as antifilarial agents and as bronchodilators.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: March 30, 1976
    Assignee: Stanford Research Institute
    Inventors: David W. Henry, Priscilla A. Sturm